Cowen and Company’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-310,700
Closed -$7.77K 651
2022
Q4
$7.77K Buy
+310,700
New +$3.2M ﹤0.01% 432
2022
Q1
Sell
-104,500
Closed -$118K 692
2021
Q4
$118K Buy
104,500
+68,900
+194% +$1.9M 0.01% 355
2021
Q3
$10K Buy
35,600
+23,100
+185% +$800K ﹤0.01% 525
2021
Q2
$4K Sell
12,500
-137,500
-92% -$5.59M ﹤0.01% 566
2021
Q1
$53K Buy
+150,000
New +$6.92M ﹤0.01% 381

Other funds holding MSOS

Cowen and Company's MSOS Position: Q4 2023 in Review

Cowen and Company sold out of AdvisorShares Pure US Cannabis ETF (MSOS) in Q4 2023, closing a stake of 6,139,280 shares — an estimated $48.7M sold.

Cowen and Company first reported a position in MSOS in Q2 2021 and held it in 9 quarters. The position peaked at $48.7M in Q3 2023. 171 funds tracked by Wall St. Rank hold MSOS as of Q4 2023.

  • Cowen and Company reported no remaining AdvisorShares Pure US Cannabis ETF position as of Q4 2023 after selling out during the quarter.
  • Cowen and Company sold 6,139,280 AdvisorShares Pure US Cannabis ETF shares in Q4 2023, an estimated $48.7M.
  • Cowen and Company first reported a position in AdvisorShares Pure US Cannabis ETF in Q2 2021 and held it in 9 quarters.
  • Cowen and Company's AdvisorShares Pure US Cannabis ETF position peaked at $48.7M in Q3 2023.
  • 171 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q4 2023.

Based on Cowen and Company's 13F filing for Q4 2023, filed 8 Feb 2024.